Discontinued — last reported Q4 '24
Business Segments · Acquisitions
JANZ — Acquisitions
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2019
Last reportedQ4 2024Feb 26, 2026
Rolls up toGoodwill Additions
How to read this metric
An increase suggests active regional expansion or strategic consolidation, while zero indicates a focus on organic growth or capital preservation.
Detailed definition
Represents the capital deployed for the purchase of businesses or product lines specifically within the Japan, Australia...
Peer comparison
Commonly reported by multinational pharmaceutical firms as 'Regional M&A' or 'Business Development Spend'.
Metric ID:
vtrs_segment_janz_acquisitionsHistorical Data
8 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Range$0.00 – $0.00
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Viatris's janz — acquisitions?
- Viatris (VTRS) reported janz — acquisitions of $0.00 in Q4 2024.
- What does janz — acquisitions mean?
- The amount of capital spent to acquire businesses or assets within the JANZ region.